Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Horizon Therapeutics (HZNP)

Horizon Therapeutics (HZNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,684,036
  • Shares Outstanding, K 225,893
  • Annual Sales, $ 2,200 M
  • Annual Income, $ 389,800 K
  • 60-Month Beta 1.05
  • Price/Sales 11.59
  • Price/Cash Flow 21.67
  • Price/Book 6.26
Trade HZNP with:

Options Overview Details

View History
  • Implied Volatility 40.65%
  • Historical Volatility 19.71%
  • IV Percentile 25%
  • IV Rank 24.36%
  • IV High 68.32% on 11/10/20
  • IV Low 31.74% on 08/12/21
  • Put/Call Vol Ratio 0.54
  • Today's Volume 3,839
  • Volume Avg (30-Day) 2,046
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 35,059
  • Open Int (30-Day) 31,293

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.54
  • Number of Estimates 6
  • High Estimate 1.60
  • Low Estimate 1.47
  • Prior Year 1.74
  • Growth Rate Est. (year over year) -11.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
106.63 +9.22%
on 10/01/21
116.80 -0.29%
on 10/21/21
+6.70 (+6.10%)
since 09/21/21
3-Month
95.50 +21.95%
on 07/22/21
116.80 -0.29%
on 10/21/21
+20.29 (+21.10%)
since 07/21/21
52-Week
66.41 +75.37%
on 12/21/20
116.80 -0.29%
on 10/21/21
+42.19 (+56.81%)
since 10/21/20

Most Recent Stories

More News
Newly Published Data Continue to Support Long-Term Efficacy of TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED)

Horizon Therapeutics plc (Nasdaq: HZNP) today announced additional data supporting the long-term efficacy of TEPEZZA for the treatment of TED. Data were published in Ophthalmology . TEPEZZA is the first...

HZNP : 116.46 (+2.43%)
3 Reasons Why Growth Investors Shouldn't Overlook Horizon Therapeutics (HZNP)

Horizon Therapeutics (HZNP) possesses solid growth attributes, which could help it handily outperform the market.

HZNP : 116.46 (+2.43%)
Biogen's (BIIB) Tofersen Reports Mixed Data From ALS Study

Biogen's (BIIB) phase III study evaluating tofersen for ALS with SOD1 mutation fails to meet the primary endpoint of the study. However, the study shows signs of reduced disease progression with tofersen....

REGN : 569.37 (+1.18%)
BIIB : 270.21 (+1.37%)
HZNP : 116.46 (+2.43%)
IONS : 30.33 (-0.62%)
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

Sector ETF report for PTH

PTH : 159.78 (+1.24%)
MRNA : 339.57 (+1.97%)
IDXX : 645.24 (+0.47%)
HZNP : 116.46 (+2.43%)
XLV : 131.14 (+0.41%)
VHT : 254.17 (+0.55%)
Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?

Anthem's (ANTM) third-quarter results are likely to reflect gains from increased premiums, and strong membership growth across its Medicare and Medicaid businesses, partly offset by rising expenses.

HCA : 260.00 (+3.64%)
HZNP : 116.46 (+2.43%)
ANTM : 430.41 (+1.50%)
AVTR : 38.77 (+0.49%)
This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

HZNP : 116.46 (+2.43%)
New Data Reinforce the Relationship Between B-Cell Depletion and Improved Outcomes in People Receiving UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Horizon Therapeutics plc (Nasdaq: HZNP) today announced results from a new analysis of the UPLIZNA pivotal Phase 2/3 N-MOmentum trial indicating a correlation between the depth of B-cell depletion and...

HZNP : 116.46 (+2.43%)
Boston Scientific (BSX) Reports Data Backing Eluvia Stent

The positive data demonstrated the superiority of Boston Scientific's (BSX) Eluvia stent compared to bare metal stents in treating patients with peripheral artery disease.

BSX : 44.87 (+0.90%)
VRTX : 187.09 (+0.86%)
AMN : 98.28 (+4.02%)
HZNP : 116.46 (+2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. ...

See More

Key Turning Points

3rd Resistance Point 120.97
2nd Resistance Point 118.89
1st Resistance Point 117.67
Last Price 116.46
1st Support Level 114.37
2nd Support Level 112.29
3rd Support Level 111.07

See More

52-Week High 116.80
Last Price 116.46
Fibonacci 61.8% 97.55
Fibonacci 50% 91.61
Fibonacci 38.2% 85.66
52-Week Low 66.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar